Sandoz Products and services Patients Careers CSR Press room Contact Accessible health Medicines available to 90% of the world's population Sandoz, a division of the Novartis group, is a global leader in generic and biosimilar medicines committed to finding innovative solutions that make quality medicines accessible to more than 90% of the world's population. Read more SANDOZ QUALITY BIOSIMILARS INNOVATION RSS Sandoz Sandoz, the generic drugs division of the Novartis group, is a world leader in the development, production and marketing of quality generic drugs and biosimilars. Read more Products and services Our main activity is the development, production and commercialization of generic drugs. Our global presence enables us to understand customer needs and add value to our business by offering high-quality products and services at affordable prices. Our formulary in Spain is made up of more than 150 molecules and almost 500 presentations that provide services to most therapeutic areas, among which we highlight: Read more FAQ's Generic Drug FAQs. Read more> Social media Last News The extrapolation of indications in biosimilars present at the IX Symposium on Rheumatoid Arthritis of the SER / FER Read more October 04, 2016 Sandoz invites young entrepreneurs to participate in the Sandoz HACk, a global competition to help solve the challenges of access to health Read more September 28, 2016 Transplant TODAY is born, a new information service about the TTS 2016 Transplant Congress Read more August 16, 2016 Action against Ebola Novartis works to provide scientific and humanitarian support to countries affected by Ebola. More information Sandoz Responds Sandoz Responde provides an uninterrupted centralized service from 8:30 a.m. to 7:00 p.m. from Monday to Friday. If you want to send an email to Sandoz Responde, click directly on the image. History Virtual tour The history Sandoz Websites Sandoz Websites You are on the website of Sandoz International. Please select from the above dropdown to visit a local website. Contact us Site Map terms of use Privacy Policy Cookies policy Report an adverse reaction Report a complaint about a product to Novartis company